Results of a randomized clinical trial of medical versus surgical management of infants and children with grades III and IV primary vesicoureteral reflux (United States). The International Reflux Study in Children
- PMID: 1433585
- DOI: 10.1016/s0022-5347(17)36998-7
Results of a randomized clinical trial of medical versus surgical management of infants and children with grades III and IV primary vesicoureteral reflux (United States). The International Reflux Study in Children
Abstract
A total of 132 infants and children with grades III and IV primary vesicoureteral reflux was entered into a prospective trial comparing medical to surgical management. Inclusion criteria were an age not exceeding 10 years and a glomerular filtration rate of at least 70 ml. per minute per 1.73 m.2. Children with significant urinary tract malformations and clinical signs/symptoms of dysfunctional voiding were not accepted into the trial. Medical therapy consisted of continuous low dose antibiotic prophylaxis until vesicoureteral reflux resolved. The type of surgical procedure used for the correction of reflux was left to the discretion of the surgeon. Outcome variables included the appearance or progression of renal lesions, rate of renal growth, recurrence rate of urinary tract infection or pyelonephritis, changes in total kidney glomerular filtration rate, development of hypertension and resolution rate of vesicoureteral reflux. Followup at 6, 18, 36 and 54 months after entry included, in addition to history and physical examination, voiding cystourethrography, excretory urography and a urine culture. Of the patients 68 were allocated to the medical group and 64 to the surgical group. They were stratified for age, sex and preexisting renal scarring. Of the patients 10% were boys, 47% were between 2 and 6 years old at entry, 93% had a history of pyelonephritis, 67% had either scarring or thinning of the parenchyma at entry, 87% had grade IV vesicoureteral reflux in at least 1 unit and 56% had bilateral reflux. There were no significant differences in the frequency distribution of entry characteristics between the patients allocated to either group. New renal scarring developed in 22% of medical and 31% of surgical patients (p < 0.4). Growth of kidneys with grade IV vesicoureteral reflux was slightly less than normal in the medical (-0.67 +/- 0.15 standard deviation) and surgical (-0.42 +/- 0.11 standard deviation) groups (p < 0.7). Pyelonephritis occurred in 15 medical patients versus 5 surgical patients (p < 0.05). There was no significant change in glomerular filtration rate within each treatment group and no difference in glomerular filtration rate between groups. No patient had hypertension during the followup period. The disappearance rate of vesicoureteral reflux in patients with grade IV reflux was approximately 8% per year. Of the medical patients 75% still had vesicoureteral reflux after 3 years of observation.(ABSTRACT TRUNCATED AT 400 WORDS)
Similar articles
-
Characteristics at entry of children with severe primary vesicoureteral reflux recruited for a multicenter, international therapeutic trial comparing medical and surgical management. The International Reflux Study in Children.J Urol. 1992 Nov;148(5 Pt 2):1644-9. doi: 10.1016/s0022-5347(17)36993-8. J Urol. 1992. PMID: 1433580 Clinical Trial.
-
Medical management of mild and moderate vesicoureteral reflux: followup studies of infants and young children. A preliminary report of the Southwest Pediatric Nephrology Study Group.J Urol. 1992 Nov;148(5 Pt 2):1683-7. doi: 10.1016/s0022-5347(17)37002-7. J Urol. 1992. PMID: 1433588
-
Cessation of vesicoureteral reflux for 5 years in infants and children allocated to medical treatment. The International Reflux Study in Children.J Urol. 1992 Nov;148(5 Pt 2):1662-6. doi: 10.1016/s0022-5347(17)36997-5. J Urol. 1992. PMID: 1433584 Clinical Trial.
-
Role of prophylaxis in vesicoureteral reflux.Curr Opin Urol. 2007 Jul;17(4):252-6. doi: 10.1097/MOU.0b013e3281ddb2db. Curr Opin Urol. 2007. PMID: 17558268 Review.
-
Primary Vesicoureteral Reflux and Renal Scarring.Pediatr Clin North Am. 2022 Dec;69(6):1115-1129. doi: 10.1016/j.pcl.2022.07.007. Epub 2022 Oct 29. Pediatr Clin North Am. 2022. PMID: 36880925 Review.
Cited by
-
Postoperative medium-term follow-up of patients with bilateral, massive primary vesicorenal reflux and reduced renal function at presentation.Pediatr Surg Int. 1996 Jun;11(5-6):334-8. doi: 10.1007/BF00497806. Epub 2013 Sep 21. Pediatr Surg Int. 1996. PMID: 24057709
-
Surgical management of vesicoureteral reflux in pediatric patients.World J Urol. 2004 Jun;22(2):96-106. doi: 10.1007/s00345-004-0408-x. Epub 2004 Jun 18. World J Urol. 2004. PMID: 15221260 Review.
-
Embryology and anatomy of the vesicoureteric junction with special reference to the etiology of vesicoureteral reflux.Ther Adv Urol. 2009 Dec;1(5):243-50. doi: 10.1177/1756287209348985. Ther Adv Urol. 2009. PMID: 21789071 Free PMC article.
-
The outcome of surgery versus medical management in the treatment of vesicoureteral reflux.Adv Urol. 2008;2008:437560. doi: 10.1155/2008/437560. Adv Urol. 2008. PMID: 18670634 Free PMC article.
-
Antimicrobial prophylaxis.Arch Dis Child. 1999 Apr;80(4):388-92. doi: 10.1136/adc.80.4.388. Arch Dis Child. 1999. PMID: 10086953 Free PMC article. Review. No abstract available.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources